Francesca Messa

735 total citations
28 papers, 255 citations indexed

About

Francesca Messa is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Francesca Messa has authored 28 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Francesca Messa's work include Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Francesca Messa is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Francesca Messa collaborates with scholars based in Italy, United States and United Kingdom. Francesca Messa's co-authors include Daniela Cilloni, Giuseppe Saglio, Enrico Gottardi, Milena Fava, M Bertini, Carlo Marinone, Andrea Gallamini, Dario Ferrero, Alessandro Levis and Patrizia Scaravaglio and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Francesca Messa

27 papers receiving 250 citations

Peers

Francesca Messa
Ying‐Jung Huang Taiwan
Barbara Rocca Italy
Marilena Caresana Italy
Matthew Smith United Kingdom
Teresa Sadras Australia
Pamela Acha Spain
Bartlomiej Getta United States
Jean‐Valère Malfuson France
Berna Beverloo Netherlands
Laurence Baranger France
Ying‐Jung Huang Taiwan
Francesca Messa
Citations per year, relative to Francesca Messa Francesca Messa (= 1×) peers Ying‐Jung Huang

Countries citing papers authored by Francesca Messa

Since Specialization
Citations

This map shows the geographic impact of Francesca Messa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Messa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Messa more than expected).

Fields of papers citing papers by Francesca Messa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Messa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Messa. The network helps show where Francesca Messa may publish in the future.

Co-authorship network of co-authors of Francesca Messa

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Messa. A scholar is included among the top collaborators of Francesca Messa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Messa. Francesca Messa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernardoni, Roberto, Giorgia Giordani, Francesca Messa, et al.. (2018). A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia. Haematologica. 104(4). 717–728. 8 indexed citations
2.
Arruga, Francesca, Francesca Messa, Monica Pradotto, et al.. (2010). Abstract 251: Disabled gene is involved in CML progression and its expression level at diagnosis can predict major molecular response (MMR) to imatinib therapy. Cancer Research. 70(8_Supplement). 251–251. 1 indexed citations
3.
Farruggia, Piero, Paolo D’Angelo, Antonio Acquaviva, et al.. (2009). HYPEREOSINOPHILIC SYNDROME IN CHILDHOOD: Clinical and Molecular Features of Two Cases. Pediatric Hematology and Oncology. 26(3). 129–135. 6 indexed citations
4.
Cilloni, Daniela, Francesca Arruga, Francesca Messa, et al.. (2009). Disabled Gene Is Involved in CML Progression and Its Expression Level at Diagnosis Can Predict Major Molecular Response (MMR) to Imatinib Therapy.. Blood. 114(22). 3964–3964. 1 indexed citations
5.
6.
Cilloni, Daniela, Monica Pradotto, Francesca Messa, et al.. (2009). Identification of Rab5 as a Gene Involved in Chronic Myeloid Leukemia (CML) Progression.. Blood. 114(22). 3470–3470. 1 indexed citations
7.
Defilippi, Ilaria, Sonia Carturan, Antonella Roetto, et al.. (2008). Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies. Acta Haematologica. 120(1). 47–50. 1 indexed citations
8.
Cilloni, Daniela, Cristina Panuzzo, Francesca Messa, et al.. (2008). Imatinib Induced Re-Activation of FoxO3 Transcription Factor in CML Is Responsible for the Induction of a Quiescent Status of CD34 Leukaemic Progenitor Cells.. Blood. 112(11). 1090–1090. 1 indexed citations
9.
Messa, Emanuela, Ilaria Defilippi, Antonella Roetto, et al.. (2008). Deferasirox Is the Only Iron Chelator Acting as a Potent NF-KB Inhibitor in Myelodysplastic Syndromes. Blood. 112(11). 2671–2671. 8 indexed citations
10.
Bracco, Enrico, Marco Lo Iacono, Francesca Arruga, et al.. (2008). Single Base Pair Mutation Detection by PNA Direct PCR Clamping: Application to Bcr-Abl T315I Mutation. Blood. 112(11). 4224–4224. 1 indexed citations
11.
Bracco, Enrico, Valentina Rosso, Francesca Arruga, et al.. (2008). Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction.. Blood. 112(11). 1093–1093. 2 indexed citations
12.
Cilloni, Daniela, Francesca Arruga, Sonia Carturan, et al.. (2008). EphA3 Kinase Is Constitutively Activated in Chronic Myeloid Leukaemia during Progression to Accelerated and Blast Crisis and It Could Represent a New Molecular Target.. Blood. 112(11). 1092–1092. 3 indexed citations
13.
Cilloni, Daniela, Cristina Panuzzo, Francesca Messa, et al.. (2007). FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.. Blood. 110(11). 1251–1251. 1 indexed citations
14.
Morotti, Alessandro, Daniela Cilloni, Francesca Messa, et al.. (2006). Valproate enhances imatinib‐induced growth arrest and apoptosis in chronic myeloid leukemia cells. Cancer. 106(5). 1188–1196. 30 indexed citations
15.
Cilloni, Daniela, Emanuela Messa, Francesca Messa, et al.. (2006). Genetic Abnormalities as Targets for Molecular Therapies in Myelodysplastic Syndromes. Annals of the New York Academy of Sciences. 1089(1). 411–423. 7 indexed citations
16.
Rondoni, Michela, Emanuela Ottaviani, Pier Paolo Piccaluga, et al.. (2006). FIP1L1-PDGFRalpha Positive Hypereosinophilic Syndrome (HES). The Response to Imatinib (IM) Is Durable. A Report of 21 Patients with a Follow-Up of 12 to 67 Months.. Blood. 108(11). 2700–2700. 3 indexed citations
17.
Messa, Francesca, Sonia Carturan, Francesca Arruga, et al.. (2004). Myelodysplastic Syndromes. Annals of the New York Academy of Sciences. 1028(1). 400–408. 5 indexed citations
18.
Cilloni, Daniela, Francesca Messa, Enrico Gottardi, et al.. (2004). Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation. Cancer. 101(5). 979–988. 26 indexed citations
19.
Cilloni, Daniela, Francesca Messa, Francesca Arruga, et al.. (2004). The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance.. Blood. 104(11). 2940–2940. 1 indexed citations
20.
Cilloni, Daniela, Sonia Carturan, Enrico Gottardi, et al.. (2003). Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias. Blood. 102(7). 2705–2706. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying‐Jung Huang Breakdown of academic impact, for papers by Barbara Rocca Breakdown of academic impact, for papers by Marilena Caresana Breakdown of academic impact, for papers by Matthew Smith Breakdown of academic impact, for papers by Teresa Sadras Breakdown of academic impact, for papers by Pamela Acha Breakdown of academic impact, for papers by Bartlomiej Getta Breakdown of academic impact, for papers by Jean‐Valère Malfuson Breakdown of academic impact, for papers by Berna Beverloo Breakdown of academic impact, for papers by Laurence Baranger
Rankless by CCL
2026